MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Total Liabilities 2011-2026 | OFIX
Annual Total Liabilities Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 401 M | 390 M | 327 M | 122 M | 140 M | 169 M | 168 M | 131 M | 109 M | 109 M | 110 M | 93.6 M | 113 M | 105 M | 380 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 401 M | 93.6 M | 191 M |
Quarterly Total Liabilities Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 390 M | 379 M | 365 M | 390 M | 342 M | 336 M | 336 M | 327 M | 290 M | 261 M | 253 M | 122 M | 116 M | - | 126 M | 140 M | 136 M | 140 M | 159 M | 169 M | 169 M | 169 M | 169 M | 168 M | 168 M | 168 M | 168 M | 131 M | 131 M | 131 M | 131 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 109 M | 110 M | 110 M | 110 M | 110 M | 93.3 M | 93.6 M | 93.6 M | 93.6 M | 116 M | 116 M | 116 M | 116 M | 108 M | 105 M | 105 M | 105 M | 393 M | 389 M | 389 M | 380 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 393 M | 93.3 M | 183 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
52 M | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
AxoGen
AXGN
|
92.8 M | $ 33.03 | -4.08 % | $ 1.52 B | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.07 | -1.09 % | $ 862 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.25 | 1.79 % | $ 1.66 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 36.66 | -0.27 % | $ 5.46 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 62.57 | -0.4 % | $ 92.6 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.41 | 0.48 % | $ 266 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 34.54 | -0.72 % | $ 1.07 B | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.62 | 5.64 % | $ 38.6 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
EDAP TMS S.A.
EDAP
|
34.6 M | $ 3.5 | 3.24 % | $ 131 M |  France |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 81.26 | 0.26 % | $ 47.5 B | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.6 | 0.04 % | $ 122 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 170.52 | -0.05 % | $ 12.8 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.87 | 0.27 % | $ 1.14 M | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.42 | 3.38 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 0.99 | 1.47 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
14.2 M | $ 96.6 | 0.38 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.01 | -2.12 % | $ 2.95 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.95 | -0.68 % | $ 374 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.97 | -1.49 % | $ 71.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.38 | 3.38 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
43.4 B | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.89 | -0.89 % | $ 575 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.69 | 3.22 % | $ 28.9 M | USA |